SCHEMBL30767718

SCHEMBL30767718

c1ccc2nc(-c3n[nH]c4ccccc34)ncc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.53
FLT1 P17948 1/20 0.53
KDM4E B2RXH2 4/20 0.50
IDO1 P14902 3/20 0.50
ALDH1A1 P00352 2/20 0.50
GAA P10253 2/20 0.50
ALPL P05186 1/20 0.50
HPGD P15428 1/20 0.50
TTK P33981 1/20 0.50
MAPK10 P53779 1/20 0.50
ITK Q08881 4/20 0.49
CYP1A2 P05177 3/20 0.49
LRRK2 Q5S007 2/20 0.47
MAP2K4 P45985 2/20 0.44
ROCK1 Q13464 1/20 0.42
AURKA O14965 1/20 0.42
GRM4 Q14833 1/20 0.41
MAPK1 P28482 1/20 0.41
MAPKAPK3 Q16644 1/20 0.41
MAPK6 Q16659 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4502048 0.76 CYP1A2 (0.57) KDM4EALDH1A1HPGDCYP1A2ROCK1
SCHEMBL17179205 0.75 PIM1 (0.60) FGFR1FLT1KDM4EIDO1ALDH1A1
SCHEMBL19402616 0.75 KDM4E (0.49) FGFR1FLT1KDM4EIDO1ALDH1A1
SCHEMBL422210 0.75 KDM4E (0.46) FGFR1FLT1KDM4EIDO1ALDH1A1
SCHEMBL1287897 0.74 LRRK2 (0.68) FGFR1FLT1KDM4EIDO1ALDH1A1
SCHEMBL2189184 0.74 FGFR1 (0.55) FGFR1FLT1KDM4EIDO1ALDH1A1
SCHEMBL29363709 0.74 FGFR1 (0.55) FGFR1FLT1KDM4EIDO1ALDH1A1
SCHEMBL14099190 0.74 CYP1A2 (0.53) KDM4EALDH1A1HPGDCYP1A2GPR3
SCHEMBL31742507 0.73 LRRK2 (0.57) FGFR1FLT1KDM4EIDO1ALDH1A1
SCHEMBL30527184 0.73 CYP1A2 (0.60) KDM4EALDH1A1HPGDCYP1A2GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4719608-A1 QUINAZOLINYL-INDAZOLE DERIVATIVES AS THERAPEUTIC COMPOUNDS FOR HIV GILEAD SCIENCES, INC. (US) 2026-04-08 EP disclosed
EP-4719608-A1 QUINAZOLINYL-INDAZOLE DERIVATIVES AS THERAPEUTIC COMPOUNDS FOR HIV GILEAD SCIENCES, INC. (US) 2026-04-08 EP disclosed
WO-2024249592-A1 QUINAZOLINYL-INDAZOLE DERIVATIVES AS THERAPEUTIC COMPOUNDS FOR HIV GILEAD SCIENCES, INC. (US) 2024-12-05 WO disclosed
WO-2024249592-A1 QUINAZOLINYL-INDAZOLE DERIVATIVES AS THERAPEUTIC COMPOUNDS FOR HIV GILEAD SCIENCES, INC. (US) 2024-12-05 WO disclosed
EP-3873607-B1 QUINAZOLINYL-INDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV HEALTHCARE UK NO 5 LTD (GB) 2023-11-29 EP disclosed
EP-3873607-C0 QUINAZOLINYL-INDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV HEALTHCARE UK NO 5 LTD (GB) 2023-11-29 EP disclosed